Introduction: Weaver syndrome (WS) is a rare autosomal dominant disorder characterized by distinctive facial features, pre- and post-natal overgrowth, macrocephaly, and variable developmental delay. The characteristic facial features are ocular hypertelorism, a broad forehead, almond-shaped palpebral fissures and, in early childhood, large, fleshy ears, a pointed “stuck-on” chin with horizontal skin creases, and retrognathia. Heterozygous pathogenic/likely pathogenic variants in the enhancer of zeste homolog 2 (EZH2) gene are responsible for WS. Case Presentation: Here, we report a male patient with a heterozygous likely pathogenic variant in EZH2 gene who has tall stature, distinctive facial features, mild development delay, hypoxic-ischemic encephalopathy with a MRI finding of periventricular leukomalacia, gingival hypertrophy, and early onset high hypermetropia. Conclusion: This case demonstrates the importance of reporting detailed molecular and clinical findings in patients to expand the genotypic and phenotypic findings of this rare syndrome.

1.
Al-Salem A, Alshammari MJ, Hassan H, Alazami AM, Alkuraya FS. Weaver syndrome and defective cortical development: a rare association. Am J Med Genet A. 2013;161A(1):225–7.
2.
Gibson WT, Hood RL, Zhan SH, Bulman DE, Fejes AP, Moore R, et al. Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet. 2012;90(1):110–8.
3.
Gurbuz T, Tan H. Oral health status in epileptic children. Pediatr Int. 2010;52:279–83.
4.
Lui JC, Barnes KM, Dong L, Yue S, Graber E, Rapaport R, et al. EZH2 mutations found in the Weaver overgrowth syndrome cause a partial loss of H3K27 histone m ethyltransferase activity. J Clin Endocrinol Metab. 2018;103(2):1470–8.
5.
Mezer E, Meyer E, Wygnansi-Jaffe T, Haase W, Shauly Y, Biglan AW. The long-term outcome of the refractive error in children with hypermetropia. Graefes Arch Clin Exp Ophthalmol. 2015;253(7):1013–9.
6.
Oh I, Kim B, Lee J-S, Kim MJ, Cho SI, Park SS, et al. First Korean case of Weaver syndrome along with neuroblastoma and genetic confirmation of EZH2 variant. Lab Med Online. 2023;13(1):48–52.
7.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–24.
8.
Suri T, Dixit A. The phenotype of EZH2 haploinsufficiency-1.2-Mb deletion at 7q36.1 in a child with tall stature and intellectual disability. Am J Med Genet A. 2017;173(10):2731–5.
9.
Tatton-Brown K, Hanks S, Ruark E, Zachariou A, Duarte SDV, Ramsay E, et al. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. Oncotarget. 2011;2(12):1127–33.
10.
Tatton-Brown K, Murray A, Hanks S, Douglas J, Armstrong R, Banka S, et al. Weaver syndrome and EZH2 mutations: clarifying the clinical phenotype. Am J Med Genet A. 2013;161A(12):2972–80.
11.
Tatton-Brown K, Rahman N. EZH2-related overgrowth gene reviews®; 2018.
12.
Turkkahraman D, Sakarya ANP, Randa NC. A novel EZH2 gene variant in a case of Weaver syndrome with postaxial polydactyly. Am J Med Genet A. 2021;185(7):2234–7.
13.
Usemann J, Ernst T, Schafer V, Lehmberg K, Seeger K. EZH2 mutation in an adolescent with Weaver syndrome developing acute myeloid leukemia and secondary hemophagocytic lymphohistiocytosis. Am J Med Genet A. 2016;170A(5):1274–7.
14.
Villani A, Greer MLC, Kalish JM, Nakagawara A, Nathanson KL, Pajtler KW, et al. Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk. Clin Cancer Res. 2017;23(12):e83–90.
15.
Weaver DD, Graham CB, Thomas IT, Smith DW. A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. J Pediatr. 1974;84(4):547–52.
You do not currently have access to this content.